Cancer Network | Brain Cancer
167 FOLLOWERS
Get latest updates and information related to Brain Cancer.
Cancer Network | Brain Cancer
1w ago
Findings from a phase 1b trial support the tolerability and potential survival benefit of CAN-3110 as a treatment for patients with recurrent high-grade glioma ..read more
Cancer Network | Brain Cancer
1w ago
Findings highlighted tumor reductions in patients with recurrent glioblastoma who received CART-EGFR-IL13Rα2 cells at 2 dose levels ..read more
Cancer Network | Brain Cancer
2M ago
Survival Advantage Demonstrated With Higher-Dose Rhenium-186 Nanoliposome in Recurrent Glioma The FDA has followed the recommendation of its Oncologic Drugs Advisory Committee and issued a complete response letter denying approval to 131I-omburtamab as a treatment for central nervous system and leptomeningeal metastases stemming from neuroblastoma. Radiosurgery and Immunotherapy for Melanoma Patients With Brain Metastases The preliminary safety and efficacy of SONALA-001 is being assessed as part of the SDT-201 study in diffuse intrinsic pontine glioma. FDA Gives Priority Review to Tovorafenib ..read more
Cancer Network | Brain Cancer
3M ago
Eflornithine, which was approved in adult and pediatric patients with high-risk neuroblastoma, was assessed in an externally controlled trial comparing results from Study 3b and Study ANBL0032 ..read more
Cancer Network | Brain Cancer
4M ago
The preliminary safety and efficacy of SONALA-001 is being assessed as part of the SDT-201 study in diffuse intrinsic pontine glioma ..read more
Cancer Network | Brain Cancer
5M ago
The FDA has set a Prescription Drug User Fee Act date of April 30, 2024 for tovorafenib as a treatment for pediatric patients with relapsed or progressive low-grade glioma ..read more
Cancer Network | Brain Cancer
5M ago
MDNA55 appears tolerable and effective in a cohort of patients enrolled in a phase 2b trial, showing sustained efficacy in subgroup analyses ..read more
Cancer Network | Brain Cancer
5M ago
Overall survival is expected to continue improving among patients with glioblastoma being treated with frontline olaptesed pegol plus radiotherapy and bevacizumab who remain on the phase 1/2 GLORA study ..read more
Cancer Network | Brain Cancer
5M ago
Findings from a phase 1 trial highlight the potential tolerability and efficacy of ABM-1310 as a treatment for patients with BRAF-mutated solid tumors ..read more